|
Real-time Estimate
Cboe Europe
13:01:55 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 535.25 SEK | -0.70% |
|
+1.42% | -2.46% |
| 09-15 | Odin Small Cap rose 4.15% in August, 16 holdings beat expectations | FW |
| 09-09 | PriorNilsson Evolve Global rose 0.49 percent in August, increased exposure to Kitron and Scanfil | FW |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 8,072 | - | - |
| Change | - | 78.07% | -6.99% | -2.49% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,155 | 7,917 | 7,676 |
| Change | - | 83.61% | -8.9% | -2.44% | -2.92% | -3.04% |
| P/E | 29.1x | 42.9x | - | 31.8x | 27x | 23.8x |
| PBR | - | 6.95x | - | 4.71x | 4x | 3.43x |
| PEG | - | 2.1x | - | - | 1.5x | 1.8x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.37x | 3.01x | 2.76x |
| EV / Revenue | - | 5.08x | 3.97x | 3.4x | 2.95x | 2.62x |
| EV / EBITDA | - | 23.7x | 18.3x | 14.8x | 12.5x | 11.1x |
| EV / EBIT | - | 33.7x | 27.6x | 22x | 18.1x | 16x |
| EV / FCF | - | 28.8x | 26.4x | 44.1x | 22.1x | 18.7x |
| FCF Yield | - | 3.47% | 3.79% | 2.27% | 4.53% | 5.36% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.97 | 19.95 | 22.62 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,686 | 2,927 |
| EBITDA 1 | - | 387.7 | 456.3 | 551.5 | 632 | 694 |
| EBIT 1 | - | 272.3 | 302.9 | 370 | 437 | 479.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 258 | 319 | 356 |
| Net Debt 1 | - | 276.5 | 81.3 | 83 | -155 | -395.5 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 539.00 | 539.00 | 539.00 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 31/01/24 | 31/01/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.4x | 14.79x | - | 819M | |
| 24.7x | 10.7x | 17.74x | 1.93% | 35.72B | |
| 15.27x | 7.88x | 12.77x | 7.47% | 19.5B | |
| 16.74x | 7.48x | 12.2x | 3.94% | 15.18B | |
| 23.89x | 4.69x | 8.15x | 3.16% | 3.67B | |
| 7.9x | 0.95x | 4.95x | 4.72% | 1.27B | |
| 12.44x | 13.94x | 13.3x | 5.39% | 920M | |
| 8.52x | 7.73x | 8.32x | 6.33% | 775M | |
| 6.85x | 6.75x | 24.4x | 5.01% | 557M | |
| Average | 14.54x | 7.06x | 12.96x | 4.74% | 8.71B | |
| Weighted average by Cap. | 20.02x | 8.84x | 14.65x | 3.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
